|
|
DF/HCC News
DFCI’s balanced portfolio of scientific investments The red and white flags suspended outside Dana-Farber Cancer Institute do more than simply decorate the hospital building; they sum up the dual mission inside: a dedication to discovery and commitment to care
Success of Prostate SPORE sparks renewal The DF/HCC Prostate Cancer SPORE, initially funded in 2002 and led by Philip Kantoff, MD (DFCI), has been highly successful in creating cohesion in the Prostate Cancer Program, sparking new RO1, PO1, and DOD grants, fostering innovative ideas in prostate cancer research, and advancing the careers of junior investigators
New associate director for administration already fast at work On November 15, DF/HCC welcomed Beverly Ginsburg, MBA, as the new associate director for administration, a recruitment that Director Edward J
Miss an event? Check out new calendar DF/HCC has launched an enhanced online calendar of educational events related to basic, clinical, and population science
Neighbors partner to nurture scientists of color DF/HCC and the University of Massachusetts Boston received a five-year, $4.3 million grant from the NIH to jointly develop strategies to reduce health disparities in Boston neighborhoods and to help diversify the region’s biomedical scientists
“Mini-Pipeline” expands reach of oncology seminars DF/HCC has expanded its monthly seminar series, "Pipelines in Oncology," to encompass small to mid-size biotechnology companies
New funding accelerates research on B-cell lymphomas Grants and philanthropic donations -- the fiscal engine of cancer research -- fuel scientific discoveries in the lab and new therapies in the clinic that might otherwise remain stalled
Displaying results 162 to 168 out of 184
|